Published in Kidney Int on December 11, 2013
Primary Nephrotic Syndrome in Adults as a Risk Factor for Pulmonary Embolism: An Up-to-Date Review of the Literature. Int J Nephrol (2014) 0.82
Primary glomerular diseases in the elderly. World J Nephrol (2015) 0.77
Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab. KI Rep (2016) 0.77
The emerging role of coagulation proteases in kidney disease. Nat Rev Nephrol (2015) 0.76
Management of Membranous Nephropathy in Western Countries. Kidney Dis (Basel) (2015) 0.75
Thrombo-prevention in membranous nephropathy: a new tool for decision making? Kidney Int (2014) 0.75
American Society of Nephrology quiz and questionnaire 2014: glomerular diseases. Clin J Am Soc Nephrol (2015) 0.75
Nephrotic syndrome-induced thromboembolism in adults. Int J Crit Illn Inj Sci (2016) 0.75
Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome. J Am Soc Nephrol (2015) 0.75
Primary Membranous Nephropathy. Clin J Am Soc Nephrol (2017) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest (2010) 10.29
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making (1998) 5.14
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol (2011) 5.06
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med (1999) 4.54
Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA (2003) 4.13
The nephrotic syndrome. N Engl J Med (1998) 3.22
Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J (2006) 3.05
A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol (2007) 2.88
Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol (2011) 2.18
High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation (2007) 2.07
Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res (2005) 2.05
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med (2010) 1.68
Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect. Clin Pharmacol Ther (1976) 1.63
Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum. J Am Soc Nephrol (2007) 1.48
Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med (2008) 1.17
The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med (1980) 1.16
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int (2011) 1.13
Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int (1983) 1.07
Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int (1994) 0.99
Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein. Am J Nephrol (1988) 0.97
Renal vein thrombosis in nephrotic syndrome--a prospective study and review. Postgrad Med J (1981) 0.96
Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosis. J Clin Epidemiol (2004) 0.94
Effect of VKORC1-1639 G>A polymorphism, body weight, age, and serum albumin alterations on warfarin response in Japanese patients. Thromb Res (2009) 0.94
Thromboembolic complications in nephrotic syndrome. Coagulation abnormalities, renal vein thrombosis, and other conditions. Postgrad Med (1984) 0.89
Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis. Clin Ther (2009) 0.87
Idiopathic membranous nephropathy in an Australian population: the incidence of thromboembolism and its impact on the natural history. Nephron (1993) 0.85
Hypoalbuminemia as a risk factor for over-anticoagulation. Am J Med (2002) 0.85
Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia. Clin Pharmacol Ther (1981) 0.79